CAMBRIDGE, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on…
Accomplished regulatory affairs veteran to lead company’s global regulatory strategy and drug product developmentNEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE)…
Ginkgo provides update on its restructuring process including significant improvement in cash flow in the fourth quarter, completion of site…
VANCOUVER, BC, Feb. 25, 2025 /PRNewswire/ -- AI users in healthcare see significant opportunities in using unstructured data for innovation…
Addition of New Team Members will Bolster Venture Builder's Expertise in Microbiome R&D and Data Science TOKYO, Feb. 25, 2025 /PRNewswire/…
LONDON, Feb. 25, 2025 /PRNewswire/ -- Contura Orthopedics is pleased to announce the launch of Contura Orthopedics (Canada) Ltd., marking a…
Strategic partnership with Microsoft provides growth opportunity for Canary Speech, which aims to set new industry standards for managing mental…
FDA feedback confirms Adial’s proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging requirement for…
Preeminent retinal disease expert panel to support Alkeus’ development programs and scienceCAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Alkeus…
SARASOTA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for…